These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25319170)

  • 1. An intellectual virtue "vaccination" for physician-pharmaceutical industry interactions.
    Ahmadi Nasab Emran S
    Acad Med; 2015 Jan; 90(1):30-2. PubMed ID: 25319170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premedical students' exposure to the pharmaceutical industry's marketing practices.
    Hodges LE; Arora VM; Humphrey HJ; Reddy ST
    Acad Med; 2013 Feb; 88(2):265-8. PubMed ID: 23269292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.
    Fadlallah R; Nas H; Naamani D; El-Jardali F; Hammoura I; Al-Khaled L; Brax H; Kahale L; Akl EA
    PLoS One; 2016; 11(8):e0160540. PubMed ID: 27556929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humble task: restoring virtue in an age of conflicted interests.
    DuBois JM; Kraus EM; Mikulec AA; Cruz-Flores S; Bakanas E
    Acad Med; 2013 Jul; 88(7):924-8. PubMed ID: 23702525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry].
    Salas SP; Osorio F M; Vial C P; Rehbein V AM; Salas A C; Beca I JP
    Rev Med Chil; 2006 Dec; 134(12):1576-82. PubMed ID: 17277877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In defense of industry-physician relationships.
    Nakayama DK
    Am Surg; 2010 Sep; 76(9):987-94. PubMed ID: 20836349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keeping modern in medicine: pharmaceutical promotion and physician education in postwar America.
    Greene JA; Podolsky SH
    Bull Hist Med; 2009; 83(2):331-77. PubMed ID: 19502716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians under the influence: social psychology and industry marketing strategies.
    Sah S; Fugh-Berman A
    J Law Med Ethics; 2013; 41(3):665-72. PubMed ID: 24088157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribers and pharmaceutical representatives: why are we still meeting?
    Fischer MA; Keough ME; Baril JL; Saccoccio L; Mazor KM; Ladd E; Von Worley A; Gurwitz JH
    J Gen Intern Med; 2009 Jul; 24(7):795-801. PubMed ID: 19424764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 20. [The relationship between medicine and medical suppliers].
    Heerlein A
    Rev Med Chil; 2014 Mar; 142(3):361-7. PubMed ID: 25052274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.